Clinical Research Directory
Browse clinical research sites, groups, and studies.
Optimized and Personalized Trans-cranial Brain Stimulation in Partial Refractory Epilepsies
Sponsor: Centre Hospitalier Universitaire, Amiens
Summary
Epilepsy is one of the most common neurological diseases, affecting between 0.5% and 1% of the general population. Therefore, new diagnostic and treatment methods are having a big impact on society. Epilepsy is also one of the most commonly diagnosed pediatric neurological disorders, with long-term implications for the quality of life of those affected and their relatives. In only two-thirds of cases, seizures can be adequately controlled with anticonvulsant drug therapy. For other patients with a drug-resistant focal epilepsy (up to around 2 million in Europe) epilepsy surgery is currently the most effective treatment. However, only 15-20% of these drug-resistant patients are eligible for epilepsy surgery. This is either because the cortical epileptogenic zone cannot be localized with sufficient precision with standard diagnostic means, or because the epileptogenic zone overlaps meaningful cortical areas, so that it cannot be surgically removed without considerable neurological deficit.
Key Details
Gender
All
Age Range
1 Year - 18 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2023-12-01
Completion Date
2027-01-01
Last Updated
2024-01-31
Healthy Volunteers
No
Interventions
transcranial electrical stimulation therapy
new procedure of non-invasive, individualized and optimized transcranial electrical stimulation therapy in the management of pharmaco-resistant focal epilepsies
Locations (1)
CHU Amiens
Amiens, France